Equity Overview
Price & Market Data
Price: $4.58
Daily Change: -$0.40 / 8.73%
Daily Range: $4.53 - $5.07
Market Cap: $194,864,496
Daily Volume: 114,049
Performance Metrics
1 Week: -0.84%
1 Month: 24.80%
3 Months: -17.16%
6 Months: 17.96%
1 Year: -20.50%
YTD: -15.23%
Company Details
Employees: 136
Sector: Health technology
Industry: Medical specialties
Country:
Details
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.